Dr. Dorothy Carol Bailey, DSW, LICSW, PIP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 228 Shelby Farms Bnd, Alabaster, AL 35007 Phone: 205-259-9924 |
Mary Kathryn Griggs, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 120 Cambridge Pointe Dr, Alabaster, AL 35007 Phone: 205-913-7570 |
Meoshia Mckinney Abrams, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 146 Shetland Trl, Alabaster, AL 35007 Phone: 205-283-8646 |
Mrs. Shermandra Ann Daniel, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1010 1st St N Ste 350, Alabaster, AL 35007 Phone: 205-679-6326 |
Felicia Pike, LICSW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 146 Big Oak Dr, Alabaster, AL 35114 Phone: 843-909-2980 |
Dorann Wilburn Tanner, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 627 Wynlake Cv, Alabaster, AL 35007 Phone: 205-506-1667 |
La Tycia Yvonne Jones, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 388 Knightsbridge, Alabaster, AL 35007 Phone: 205-266-7577 |
News Archive
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody(TM) platform, today announced the successful second closing of its Series A equity financing round. The Company raised an additional EUR 3.0 million (~USD 4.5 million) from two leading life science investors, Credit Agricole Private Equity and VIB (the prestigious Flemish research institute).
Your primary care physician may be your first choice for assistance with most health-related issues, but according a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health, primary care physicians agree they may not be the best health care professionals to give weight related counseling.
Researchers at the nanotechnology research centre imec have demonstrated biosensors based on novel nanostructure geometries that increase the sensitivity and allow to detect extremely low concentrations of specific disease markers. This paves the way to early diagnostics of for example cancer by detecting low densities of cancer markers in human blood samples.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on October 9, 2009, it received a determination letter from The NASDAQ Stock Market notifying the Company that the NASDAQ Hearing Panel (the "Panel") has granted the Company's request to remain listed on NASDAQ, subject to the Company demonstrating compliance with the NASDAQ Listing Rules (the "Listing Rules") on or before December 31, 2009 (the "Exception Period").
The research couple receives the "2013 Khalid Iqbal Lifetime Achievement Award" for its role as pioneers in investigating the role of tau in Alzheimer's disease. The award ceremony was held yesterday (10:45 am US EST) within the framework of the "Alzheimer's Association International Conference (AAIC 2013)" in Boston (USA).
› Verified 2 days ago